Haptoglobine (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Haptoglobine" in French language version.

refsWebsite

Global rank French rank

10nih.gov

4^th place

12^th place

9doi.org

2^nd place

3^rd place

4sciencedirect.com

149^th place

80^th place

2onlinejacc.org

low place

2,587^th place

2ahajournals.org

3,608^th place

659^th place

1clinchem.org

low place

1liebertpub.com

low place

4,955^th place

1archives-ouvertes.fr

1,031^st place

161^st place

ahajournals.org

atvb.ahajournals.org

(en) Andrew P Levy , Joanne E Levy, Shiri Kalet-Litman, Rachel Miller-Lotan, Pedro R Moreno et al., « Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque », Arterioscler Thromb Vasc Biol, vol. 27, n^o 1,‎ 2007, p. 134-40. (PMID 17068284, DOI 10.1161/01.ATV.0000251020.24399.a2, lire en ligne)

circres.ahajournals.org

(en) Rabea Asleh, Stuart Marsh, Mark Shilkrut, Ofer Binah, Julia Guetta, Flavio Lejbkowicz, Ben Enav, Naim Shehadeh, Yoram Kanter, Orit Lache, Osher Cohen, Nina S Levy, Andrew P Levy et al., « Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease », Circ Res, vol. 92, n^o 11,‎ 2003, p. 1193-200. (PMID 12750308, DOI 10.1161/01.RES.0000076889.23082.F1, lire en ligne)

archives-ouvertes.fr

hal.archives-ouvertes.fr

R. Engler, Protéines de la réaction inflammatoire, 1994 (lire en ligne), p. 337-443

clinchem.org

(en) M R Langlois, J R Delanghe, « Biological and clinical significance of haptoglobin polymorphism in humans », Clin Chem, vol. 42, n^o 10,‎ 1996, p. 1589-600. (PMID 8855140, lire en ligne)

doi.org

dx.doi.org

(en) Robert Roberts, « Haptoglobin, the good and the bad: is it evidence based? », J Am Coll Cardiol, vol. 61, n^o 7,‎ 2013, p. 738-40. (PMID 23312705, DOI 10.1016/j.jacc.2012.11.041, lire en ligne)
(en) Andrew P Levy, Rabea Asleh, Shany Blum, Nina S Levy, Hagit Goldenstein et al., « Haptoglobin: basic and clinical aspects », Antioxid Redox Signal, vol. 12, n^o 2,‎ 2010, p. 293-304. (PMID 19659435, DOI 10.1089/ars.2009.2793, lire en ligne)
(en) Andrew P Levy, Martin G Larson, Diane Corey, Rachel Lotan, Emelia J Benjamin et al., « Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort », Atherosclerosis, vol. 172, n^o 2,‎ 2004, p. 361-5. (PMID 15019547, DOI 10.1016/j.atherosclerosis.2003.10.014, lire en ligne)
(en) Leah E Cahill, Andrew P Levy, Stephanie E Chiuve, Majken K Jensen, Eric B Rimm et al., « Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin », J Am Coll Cardiol, vol. 61, n^o 7,‎ 2013, p. 728-37. (PMID 23312704, PMCID PMC3678553, DOI 10.1016/j.jacc.2012.09.063, lire en ligne)
(en) Leah E Cahill, Majken K Jensen, Stephanie E Chiuve, Hadar Shalom, Eric B Rimm et al., « The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype », J Am Coll Cardiol, vol. 66, n^o 16,‎ 2015, p. 1791-9. (PMID 26483103, PMCID PMC4616252, DOI 10.1016/j.jacc.2015.07.076, lire en ligne)
(en) Julia Guetta, Merav Strauss, Nina S Levy, Lana Fahoum, Andrew P Levy, « Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin », Atherosclerosis, vol. 191, n^o 1,‎ 2007, p. 48-53. (PMID 16820150, DOI 10.1016/j.atherosclerosis.2006.04.032, lire en ligne)
(en) J M Gutteridge, « The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation », Biochim Biophys Acta, vol. 917,‎ 1987, p. 219-23. (PMID 2879568, DOI 10.1016/0005-2760(87)90125-1, lire en ligne)
(en) Andrew P Levy , Joanne E Levy, Shiri Kalet-Litman, Rachel Miller-Lotan, Pedro R Moreno et al., « Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque », Arterioscler Thromb Vasc Biol, vol. 27, n^o 1,‎ 2007, p. 134-40. (PMID 17068284, DOI 10.1161/01.ATV.0000251020.24399.a2, lire en ligne)
(en) Rabea Asleh, Stuart Marsh, Mark Shilkrut, Ofer Binah, Julia Guetta, Flavio Lejbkowicz, Ben Enav, Naim Shehadeh, Yoram Kanter, Orit Lache, Osher Cohen, Nina S Levy, Andrew P Levy et al., « Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease », Circ Res, vol. 92, n^o 11,‎ 2003, p. 1193-200. (PMID 12750308, DOI 10.1161/01.RES.0000076889.23082.F1, lire en ligne)

liebertpub.com

online.liebertpub.com

(en) Andrew P Levy, Rabea Asleh, Shany Blum, Nina S Levy, Hagit Goldenstein et al., « Haptoglobin: basic and clinical aspects », Antioxid Redox Signal, vol. 12, n^o 2,‎ 2010, p. 293-304. (PMID 19659435, DOI 10.1089/ars.2009.2793, lire en ligne)

nih.gov

ncbi.nlm.nih.gov

(en) Robert Roberts, « Haptoglobin, the good and the bad: is it evidence based? », J Am Coll Cardiol, vol. 61, n^o 7,‎ 2013, p. 738-40. (PMID 23312705, DOI 10.1016/j.jacc.2012.11.041, lire en ligne)
(en) M R Langlois, J R Delanghe, « Biological and clinical significance of haptoglobin polymorphism in humans », Clin Chem, vol. 42, n^o 10,‎ 1996, p. 1589-600. (PMID 8855140, lire en ligne)
(en) Andrew P Levy, Rabea Asleh, Shany Blum, Nina S Levy, Hagit Goldenstein et al., « Haptoglobin: basic and clinical aspects », Antioxid Redox Signal, vol. 12, n^o 2,‎ 2010, p. 293-304. (PMID 19659435, DOI 10.1089/ars.2009.2793, lire en ligne)
(en) Andrew P Levy, Martin G Larson, Diane Corey, Rachel Lotan, Emelia J Benjamin et al., « Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort », Atherosclerosis, vol. 172, n^o 2,‎ 2004, p. 361-5. (PMID 15019547, DOI 10.1016/j.atherosclerosis.2003.10.014, lire en ligne)
(en) Leah E Cahill, Andrew P Levy, Stephanie E Chiuve, Majken K Jensen, Eric B Rimm et al., « Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin », J Am Coll Cardiol, vol. 61, n^o 7,‎ 2013, p. 728-37. (PMID 23312704, PMCID PMC3678553, DOI 10.1016/j.jacc.2012.09.063, lire en ligne)
(en) Leah E Cahill, Majken K Jensen, Stephanie E Chiuve, Hadar Shalom, Eric B Rimm et al., « The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype », J Am Coll Cardiol, vol. 66, n^o 16,‎ 2015, p. 1791-9. (PMID 26483103, PMCID PMC4616252, DOI 10.1016/j.jacc.2015.07.076, lire en ligne)
(en) Julia Guetta, Merav Strauss, Nina S Levy, Lana Fahoum, Andrew P Levy, « Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin », Atherosclerosis, vol. 191, n^o 1,‎ 2007, p. 48-53. (PMID 16820150, DOI 10.1016/j.atherosclerosis.2006.04.032, lire en ligne)
(en) J M Gutteridge, « The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation », Biochim Biophys Acta, vol. 917,‎ 1987, p. 219-23. (PMID 2879568, DOI 10.1016/0005-2760(87)90125-1, lire en ligne)
(en) Andrew P Levy , Joanne E Levy, Shiri Kalet-Litman, Rachel Miller-Lotan, Pedro R Moreno et al., « Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque », Arterioscler Thromb Vasc Biol, vol. 27, n^o 1,‎ 2007, p. 134-40. (PMID 17068284, DOI 10.1161/01.ATV.0000251020.24399.a2, lire en ligne)
(en) Rabea Asleh, Stuart Marsh, Mark Shilkrut, Ofer Binah, Julia Guetta, Flavio Lejbkowicz, Ben Enav, Naim Shehadeh, Yoram Kanter, Orit Lache, Osher Cohen, Nina S Levy, Andrew P Levy et al., « Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease », Circ Res, vol. 92, n^o 11,‎ 2003, p. 1193-200. (PMID 12750308, DOI 10.1161/01.RES.0000076889.23082.F1, lire en ligne)

onlinejacc.org

content.onlinejacc.org

(en) Robert Roberts, « Haptoglobin, the good and the bad: is it evidence based? », J Am Coll Cardiol, vol. 61, n^o 7,‎ 2013, p. 738-40. (PMID 23312705, DOI 10.1016/j.jacc.2012.11.041, lire en ligne)
(en) Leah E Cahill, Andrew P Levy, Stephanie E Chiuve, Majken K Jensen, Eric B Rimm et al., « Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin », J Am Coll Cardiol, vol. 61, n^o 7,‎ 2013, p. 728-37. (PMID 23312704, PMCID PMC3678553, DOI 10.1016/j.jacc.2012.09.063, lire en ligne)

sciencedirect.com

(en) Andrew P Levy, Martin G Larson, Diane Corey, Rachel Lotan, Emelia J Benjamin et al., « Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort », Atherosclerosis, vol. 172, n^o 2,‎ 2004, p. 361-5. (PMID 15019547, DOI 10.1016/j.atherosclerosis.2003.10.014, lire en ligne)
(en) Leah E Cahill, Majken K Jensen, Stephanie E Chiuve, Hadar Shalom, Eric B Rimm et al., « The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype », J Am Coll Cardiol, vol. 66, n^o 16,‎ 2015, p. 1791-9. (PMID 26483103, PMCID PMC4616252, DOI 10.1016/j.jacc.2015.07.076, lire en ligne)
(en) Julia Guetta, Merav Strauss, Nina S Levy, Lana Fahoum, Andrew P Levy, « Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin », Atherosclerosis, vol. 191, n^o 1,‎ 2007, p. 48-53. (PMID 16820150, DOI 10.1016/j.atherosclerosis.2006.04.032, lire en ligne)
(en) J M Gutteridge, « The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation », Biochim Biophys Acta, vol. 917,‎ 1987, p. 219-23. (PMID 2879568, DOI 10.1016/0005-2760(87)90125-1, lire en ligne)